Showing 591-600 of 2216 results for "".
Antiplatelet Therapies After Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/antiplatelet-therapies-after-ischemic-stroke/31862/Antiplatelet therapies are effective for prevention of secondary stroke and can be tailored to individual patient needs.Neuroinflammation in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/neuroinflammation-in-parkinson-disease/31826/Neuroinflammation plays multiple roles in the pathogenesis of Parkinson disease.Late-Onset Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/late-onset-epilepsy/31945/As the population ages, late-onset epilepsy is becoming a major public health issue with effective treatments and modifiable risk factors.Dementia Caregiver Needs
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-caregiver-needs/31802/Caregiver needs exist and can be addressed at all stages of the dementias.Teleneuro-ophthalmology
https://practicalneurology.com/diseases-diagnoses/headache-pain/teleneuro-ophthalmology/31670/Something can almost always be offered virtually for people with neuro-ophthalmologic conditions.About the Cover Artist: Within by Christopher Stowe, MGySgt, US Marine Corps (Retired)
https://practicalneurology.com/diseases-diagnoses/tbi/about-the-cover-artist-iwithini-by-christopher-stowe-mgysgt-us-marine-corps-retired/31996/Chris’ art is one way to show people his interpretation of the invisible wounds of war.Inclusive Research for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inclusive-research-for-multiple-sclerosis/31755/Inclusive research improves quality of scientific data, facilitates discovery of safety and efficacy, and assists in identifying population-specific differences.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0307-movedisorders-pdf/31203/Accurate assessment of movement disorders is crucial for clinicians to quantify their impact on patients’ quality of life and monitor disease progression. Practical Neurology’s recent article delves into various validated rating scales tailored for specific neurological conditions, enhancing objecti
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0607-movementdisorder-pdf/31164/Sydenham’s Chorea in Adolescents: Clinical Presentation and ManagementSydenham’s chorea is a critical movement disorder in adolescents, often emerging as a delayed neurological complication of acute rheumatic fever (ARF) following a Group A streptococcal infection. While clinicians might first consi